Offer - Urjas Oil for just ₹ 1 X
Gemer P 2 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes. Secondary and off-label uses of Gemer P 2 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Gemer P 2 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Gemer P 2 Tablet also has some side effects, the most common being Nausea or vomiting, Diarrhoea, Headache. Apart from the aforementioned side effects, Gemer P 2 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Gemer P 2 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Gemer P 2 Tablet is Unknown for pregnant women and Safe for women who are breastfeeding. Warnings related to Gemer P 2 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease must refrain from the use of Gemer P 2 Tablet since this can cause severe adverse effects.
Drug interactions for Gemer P 2 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Gemer P 2 Tablet is not safe while driving, and is is not addictive in nature.
Gemer P 2 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemer P 2 Tablet safe for pregnant women?
Side effects of Gemer P during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Gemer P 2 Tablet safe during breastfeeding?
Gemer P is completely safe for breastfeeding women.
What is the effect of Gemer P 2 Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Gemer P. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Gemer P 2 Tablet on the Liver?
You may experience side effects on your liver after taking Gemer P. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Gemer P 2 Tablet on the Heart?
Side effects of Gemer P rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Gemer P 2 Tablet unless your doctor advises you to do so -
Is this Gemer P 2 Tablet habit forming or addictive?
No, there is no any evidence that Gemer P 2 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Gemer P 2 Tablet as you may feel sleepy.
Is it safe?
Gemer P 2 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Gemer P 2 Tablet in mental disorders is not effective.
Interaction between Food and Gemer P 2 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Gemer P 2 Tablet together with food.
Interaction between Alcohol and Gemer P 2 Tablet
It is difficult to say anything about the effect of Gemer P 2 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033